Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Antivabio

Antivabio

USantivabio.com

Antiva is developing novel topical therapies to treat pre-cancerous lesions caused by HPV.

Facts
Year of incorporation
unknown
Revenue range (Form D)
unknown
Rounds on record
0
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
3
Financing history
0 rounds
No dated round yet.
Investors on record
3 edges
People
0 officers, 0 directors
No officer or director on record.
Timeline
2
  1. Sep 16, 2026
    Antivabio no longer listed on Adjuvant Capital, LP's portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
  2. Sep 16, 2026
    Antivabio no longer listed on Sofinnova Investments, Inc.'s portfolio page
    Removed from portfolio page Inference Venture organization websites (about, team, portfolio, thesis, news pages)
Evidence
7 observations
Every observation on this company